SlideShare a Scribd company logo
◘ AIS is defined as an episode of neurological
dysfunction caused by focal cerebral, spinal or
retinal infarction.
◘ In developed countries stroke had dropped from the
2nd to the 5th cause of death (after heart diseases,
cancer, chronic lower respiratory diseases and
accidents).
◘ On the other hand, in developing countries stroke
still impacted as the 2nd cause of death.
◘ 20% of stroke survivors are unable to return to
work, 10% will have another stroke within one
year, 30% require assistance with activities of
daily living, 18% require assistance with
ambulation, and 16% require institutional care.
◘ Better stroke prognosis is attributed to greater
awareness of stroke symptoms and improved
care within the first hours of onset.
◘ In 1996, the FDA approved IV r-tPA as the only
therapy for early AIS management and since
this date many efforts had spent to reduce the
stoke onset/needle time due to the narrow
therapeutic window.
◘ Many stroke patients are elderly who reside
alone or with their spouse with limited
support from younger generations. These
patients are unable to do anything beyond
alarming the system.
◘ Till intra-arterial reperfusion, 2 million neurons
are lost each minute and every 30-min delay
reduces the relative likelihood of a good
clinical outcome by 15%.
◘ < 1.4 % of AIS patients receive IV r-tPA in the
first 60 minutes.
◘ The rate of IV thrombolysis in the window is
3.4 – 9.1 % of AIS patients.
◘ The call to the EMS stroke center is the first
link in the SCS which must be activated at
once.
◘ The dispatcher must not leave the scene before
establishing the Time ZERO which is defined as
the time at which the patient was last known
or seen normal. .
1- Describe the various types of stroke and their etiology.
2- Discuss the imperatives for best practice in regard to
EMS stroke management.
3- List 5 or more risk factors for acute stroke.
4- Define “penumbra” and how this concept is important in
stroke.
5- Generally describe the major vessels involved in acute
ischemic stroke.
6- Discuss the “therapeutic window” for thrombolytic
therapy in stroke.
7- Identify interventions that individual EMS providers can
make to improve outcomes in stroke.
1- ABC and IV access.
2- O2 administration if Sa O2 < 95% (routine use is not recommended).
3- No need for pre-hospital management of high blood pressure or
elevated body temperature.
4- For hypotension, horizontal placement of the stretcher head and
isotonic saline.
5- No need for insulin administration in hyperglycemia.
6- IV glucose if RBS is below 60 mg/dl.
7- No benefits from the pre-hospital use of neuroprotective e.g.
nimodipine or magnesium sulphate.
(1) Rapid stroke identification.
(2) Early stabilization of vital functions.
(3) Rapid transport to closest available certified
stroke ready hospital.
- Bypass the stroke non-ready hospitals.
- Air medical transport is considered when ground
transport is >1 hour.
(4) Pre-arrival hospital notification.
Theprobabilityofstrokeis 72%in patientwith1 probabilityand85%inwhomhas3 probabilities
◘ EMS personnel should provide prehospital
notification to improve the readiness of the
hospital team which shorten the door to
needle time by about 15 minutes.
◘ Teleradiology systems had approved for sites
without in-house imaging interpretation
expertise.
◘ Tele-stroke/teleradiology evaluations of AIS
patients can be effective for correct IV r-tPA
eligibility decision making.
◘ Administration of IV r-tPA guided by tele-stroke
consultation for patients with AIS which is as
safe as the stroke centers.
◘ ABCs should be reassessed and rechecked
frequently.
◘ Stroke assessment focusing on the 4 key issues:
1- Level of consciousness.
2- Type of stroke (hemorrhagic versus non-
hemorrhagic).
3- Location of stroke (carotid versus vertebra-basilar).
4- Severity of stroke.
◘ Obtaining the exact time of stroke onset (time zero).
◘ NIHSS.
◘ CT initiation & interpretation.
◘ Anticoagulants and fibrinolytic agents should be withheld until CT has ruled
out a brain hemorrhage.
◘ Stroke Mimics (Chameleons):
- Unrecognized seizures. - Confusional states.
- Syncope. - Toxic or metabolic disorders.
- Hypoglycemia. - Brain tumors.
- Subdural hematoma. - Psychogenic.
◘ For ( * ) marked investigations, IV r-tPA should not be delayed while awaiting their results.
◘ Non-contrast brain CT or brain MRI
◘ Blood glucose
◘ Oxygen saturation
◘ Serum electrolytes/renal function tests *
◘ Complete blood count, including platelet
count *
◘ Markers of cardiac ischemia *
◘ PT/INR *
◘ Activated PTT *
◘ ECG *
All patients Selected patients
◘ Ecarin clotting time & thrombin time (if pt.
receiving direct thrombin or direct factor
Xa inhibitors).
◘ Hepatic function tests
◘ Toxicology screen
◘ Blood alcohol level
◘ Pregnancy test
◘ Arterial blood gas tests
◘ Chest radiography
◘ Lumbar puncture (if SAH is suspected
and CT scan is negative)
◘ EEG (if seizures are suspected)
◘ General care includes, (but is not limited to):
1- Prevention of aspiration.
2- Management of hypertension.
3- Management of hyper/hypo-glycemia.
4- Management of seizures.
5- Management of elevated intra-cranial pressure
(ICP).
◘ The front-line stroke-ready hospitals quickly administer r-tPA then transport patients to a more advanced
center withbetter stroke treatment facilities.
◘ Written emergency stroke care protocols.
◘ Written transfer agreement to a hospital with
neurosurgical expertise in less than 2 hours.
◘ Director of stroke care to oversee hospital stroke
policies and procedure.
◘ 24 / 7 ability to administer IV r-tPA.
◘ 24 / 7 ability to perform emergency brain CT.
◘ 24 / 7 ability to perform emergency laboratory
testing.
◘ No need of invasive catheter procedure or specialized
stroke ICU.
◘ Availability of advanced imaging techniques,
including MRI/MRA, CTA, DSA and TCD.
◘ Ready for all CVS management i.e. ischemic,
hemorrhagic and SAH.
◘ 24 / 7 ready IV r-tPA and endovascular team able for
mechanical thrombectomy.
◘ Availability of specialized stroke ICU.
◘ 24 /7 neurosurgical team able to perform aneurysm
clipping, vascular malformation surgery and carotid
endarterectomy.
◘ Bringing swift treatment to the patient, instead
of the conventional approach of awaiting the
patient’s arrival at the hospital.
◘ This strategy is based on the use of an
ambulance (mobile stroke unit) equipped
with an imaging system, a point-of-care
laboratory, a telemedicine connection to the
hospital, and appropriate medication.
◘ While building a SCS system, do not look for
the unreachable solutions, but always adjust
the system regarding the available resources.
◘ SCS is a dynamic process that needs continuous
evaluation, quality assessment and updating
to identify and solve gaps as well as disparities
in providing stroke care.
◘ Do not think about mobile stroke units while
you are wasting > extra 40 minutes in the
door / needle time.
◘ The EAN is not convinced in the value of
generalization the German STEMO trial which
decreases the alarm / needle time by about 25
minutes (52 minutes STEMO vs. 77 minutes
ordinary SCS).
◘ In Australia, air medical transport reduced alarm
/ needle time by 30 minutes.
◘ The clinical data regarding the value pre-hospital
laboratory investigations in reducing the door /
needle time are contradictory.
1- Increasing social awareness.
2- Training the EMS staff.
3- Arrangement with the Directorate of Health
Affairs in Gharbia Governorate to set up the
drip and ship strategy.
4- Financial support (governmental, third party
agencies and the civil society institutions), for
reimbursement of the r-tPA.
5- The administrative procedures, laboratory
investigations and imaging steps should be done
in the same building and simultaneously rather
than consecutively.
[1] Caplan, JAMA Neurology; 2017. doi: 10.1001/jamaneurol.2017.0006
[2] Espinoza et al. Cerebrovascular Diseases; 2016. doi: 10.1159/000444175
[3] Bahnasy et al., eNeurologicalSci 2019; doi: 10.1016/j.ensci.2019.01.003
[4] Abu-Hegazy et al. EJNPN; 2017. doi: 10.4103/1110-1083.202377
[5] Feigin et al. Circ Res; 2017. doi: 10.1161/CIRCRESAHA.116.308413
[6] Badachi et al. Annals of Indian Academy of Neurology; 2015. doi: 10.4103/0972-2327.165460
[7] Valenzuela et al. Cerebrovascular Diseases; 2016. doi: 10.1159/000444175
[8] Fonarow et al. Circulation; 2011. doi: 10.1161/CIRCULATIONAHA.110.974675
[9] Kassebaum et al. Lancet; 2016. doi: 10.1016/S0140-6736(16)31460-X
[10] Brandler et al. J. Stroke and Cerebrovascular D; 2015. doi: 10.1016/j.jstrokecerebrovasdis.2015.06.004
[11] Cheng et al. Neurohospitalist; 2015. doi: 10.1177/1941874415583116
[12] Dombrowski et al. Stroke; 2015. doi: 10.1161/STROKEAHA.115.009997
[13] Nishijima et al. Journal of the Neurological Sciences; 2017. doi: 10.1016/j.jns.2017.08.3236
[14] Farrag et al. J Neurol Sci; 2018. doi: 10.1016/j.jns.2017.11.003
[15] Ruiz et al. J. Stroke and Cerebrovascular D; 2018. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.036
[17] Hansen et al. J Neurosci Rural Pract; 2017. doi: 10.4103/jnrp.jnrp_2_17
[18] Ghandehari et al. Stroke Res Treat; 2011. doi: 10.4061/2011/686797
[19] Paul et al. Implementation Science; 2016. doi: 10.1186/s13012-016-0414-6
[20] Fernandes et al. BMJ Quality Improvement Reports. 2016. doi: 10.1136/bmjquality.u212969.w5150
[21] Powers et al. Stroke; 2018. doi: 10.1161/STR.0000000000000158
[22] Meschia et al. European Journal of Neurology; 2018. doi:10.1111/ene.13409
[23] Puolakka et al. J Am Heart Assoc; 2016. doi: 10.1161/JAHA.115.002808
Center of Neurology and Psychiatry,
Tanta University
Onset to Needle delay in Stroke Chain of Survival

More Related Content

What's hot

Non invasive evaluation of arrhythmias
Non invasive evaluation of arrhythmias Non invasive evaluation of arrhythmias
Non invasive evaluation of arrhythmias
Sunil Reddy D
 
A faster way to treat stroke
A faster way to treat strokeA faster way to treat stroke
A faster way to treat stroke
University of Calgary
 
2018 Stroke Guidelines
2018 Stroke Guidelines2018 Stroke Guidelines
2018 Stroke Guidelines
Sun Yai-Cheng
 
Stroke thrombolysis protocol
Stroke thrombolysis protocolStroke thrombolysis protocol
Stroke thrombolysis protocol
Ankit Gajjar
 
Neurovascular Devices and Clinical ApplicationsNEW [Autosaved]
Neurovascular Devices and Clinical ApplicationsNEW [Autosaved]Neurovascular Devices and Clinical ApplicationsNEW [Autosaved]
Neurovascular Devices and Clinical ApplicationsNEW [Autosaved]
Jason Cotham
 
Recent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysisRecent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysis
Dr Vipul Gupta
 
Stroke guidelines, 2015
Stroke guidelines, 2015Stroke guidelines, 2015
Stroke guidelines, 2015
Usama Ragab
 
Endovascular treatment in acute cerebral ischemia
Endovascular treatment in acute cerebral ischemiaEndovascular treatment in acute cerebral ischemia
Endovascular treatment in acute cerebral ischemia
nikhilprerana
 
Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...
Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...
Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...
Sanjay Jaiswal
 
Thrombectomy for ischemic stroke and anaesthesia
Thrombectomy for ischemic stroke and anaesthesiaThrombectomy for ischemic stroke and anaesthesia
Thrombectomy for ischemic stroke and anaesthesia
Wahid altaf Sheeba hakak
 
New Updates to Guidelines for Patients with Acute Ischemic Stroke
New Updates to Guidelines for Patients with Acute Ischemic StrokeNew Updates to Guidelines for Patients with Acute Ischemic Stroke
New Updates to Guidelines for Patients with Acute Ischemic Stroke
Dr Vipul Gupta
 
Definition and Evaluation of Transient Ischemic Attack
Definition and Evaluation of Transient Ischemic AttackDefinition and Evaluation of Transient Ischemic Attack
Definition and Evaluation of Transient Ischemic Attack
Sun Yai-Cheng
 
Risk stratification of scd
Risk stratification of scdRisk stratification of scd
Risk stratification of scd
Sunil Reddy D
 
Mechanical thrombectomy with stent retriever
Mechanical thrombectomy with stent retrieverMechanical thrombectomy with stent retriever
Mechanical thrombectomy with stent retriever
Dr Vipul Gupta
 
Society of Therapeutic Neurointerventions
Society of Therapeutic NeurointerventionsSociety of Therapeutic Neurointerventions
Society of Therapeutic Neurointerventions
Dr Vipul Gupta
 
Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy
Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP PolicyUse of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy
Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy
Sun Yai-Cheng
 
Neurointervention in hemorrhagic and ischaemic stroke
Neurointervention in hemorrhagic and ischaemic strokeNeurointervention in hemorrhagic and ischaemic stroke
Neurointervention in hemorrhagic and ischaemic stroke
Dr Vipul Gupta
 
Acute stroke early recognition and management
Acute stroke early recognition and managementAcute stroke early recognition and management
Acute stroke early recognition and management
webzforu
 
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
Arlyn Valencia, M.D.
 
Early management of acute ischemic stroke cases
Early management of acute ischemic stroke casesEarly management of acute ischemic stroke cases
Early management of acute ischemic stroke cases
Apollo Hospitals
 

What's hot (20)

Non invasive evaluation of arrhythmias
Non invasive evaluation of arrhythmias Non invasive evaluation of arrhythmias
Non invasive evaluation of arrhythmias
 
A faster way to treat stroke
A faster way to treat strokeA faster way to treat stroke
A faster way to treat stroke
 
2018 Stroke Guidelines
2018 Stroke Guidelines2018 Stroke Guidelines
2018 Stroke Guidelines
 
Stroke thrombolysis protocol
Stroke thrombolysis protocolStroke thrombolysis protocol
Stroke thrombolysis protocol
 
Neurovascular Devices and Clinical ApplicationsNEW [Autosaved]
Neurovascular Devices and Clinical ApplicationsNEW [Autosaved]Neurovascular Devices and Clinical ApplicationsNEW [Autosaved]
Neurovascular Devices and Clinical ApplicationsNEW [Autosaved]
 
Recent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysisRecent evidence for mechanical thrombolysis
Recent evidence for mechanical thrombolysis
 
Stroke guidelines, 2015
Stroke guidelines, 2015Stroke guidelines, 2015
Stroke guidelines, 2015
 
Endovascular treatment in acute cerebral ischemia
Endovascular treatment in acute cerebral ischemiaEndovascular treatment in acute cerebral ischemia
Endovascular treatment in acute cerebral ischemia
 
Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...
Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...
Stroke thrombolysis Dr Sanjay Jaiswal,consultant nerologist,Jaiswal Hospital ...
 
Thrombectomy for ischemic stroke and anaesthesia
Thrombectomy for ischemic stroke and anaesthesiaThrombectomy for ischemic stroke and anaesthesia
Thrombectomy for ischemic stroke and anaesthesia
 
New Updates to Guidelines for Patients with Acute Ischemic Stroke
New Updates to Guidelines for Patients with Acute Ischemic StrokeNew Updates to Guidelines for Patients with Acute Ischemic Stroke
New Updates to Guidelines for Patients with Acute Ischemic Stroke
 
Definition and Evaluation of Transient Ischemic Attack
Definition and Evaluation of Transient Ischemic AttackDefinition and Evaluation of Transient Ischemic Attack
Definition and Evaluation of Transient Ischemic Attack
 
Risk stratification of scd
Risk stratification of scdRisk stratification of scd
Risk stratification of scd
 
Mechanical thrombectomy with stent retriever
Mechanical thrombectomy with stent retrieverMechanical thrombectomy with stent retriever
Mechanical thrombectomy with stent retriever
 
Society of Therapeutic Neurointerventions
Society of Therapeutic NeurointerventionsSociety of Therapeutic Neurointerventions
Society of Therapeutic Neurointerventions
 
Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy
Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP PolicyUse of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy
Use of tPA for the Management of Acute Ischemic Stroke in the ED: ACEP Policy
 
Neurointervention in hemorrhagic and ischaemic stroke
Neurointervention in hemorrhagic and ischaemic strokeNeurointervention in hemorrhagic and ischaemic stroke
Neurointervention in hemorrhagic and ischaemic stroke
 
Acute stroke early recognition and management
Acute stroke early recognition and managementAcute stroke early recognition and management
Acute stroke early recognition and management
 
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
THE LATEST IN STROKE MANAGEMENT, ACUTE AND PREVENTIVE By Arlyn Valencia, M.D....
 
Early management of acute ischemic stroke cases
Early management of acute ischemic stroke casesEarly management of acute ischemic stroke cases
Early management of acute ischemic stroke cases
 

Similar to Onset to Needle delay in Stroke Chain of Survival

Identifying and managing acute stroke
Identifying and managing acute strokeIdentifying and managing acute stroke
Identifying and managing acute stroke
Ahmad Shahir
 
STEMI F5.pptx
STEMI F5.pptxSTEMI F5.pptx
STEMI F5.pptx
Mohamed Ashraf
 
2017 ESC guidelines for the management of acute
2017 ESC guidelines for the management of acute2017 ESC guidelines for the management of acute
2017 ESC guidelines for the management of acute
Iqbal Dar
 
Stroke- what's new
Stroke- what's newStroke- what's new
Stroke- what's new
Ahmad Shahir
 
a212b74434a2a0e4d2bee882e015987d.pdf
a212b74434a2a0e4d2bee882e015987d.pdfa212b74434a2a0e4d2bee882e015987d.pdf
a212b74434a2a0e4d2bee882e015987d.pdf
SuryaRaj73
 
21. premier. english
21. premier. english21. premier. english
21. premier. english
Erwin Chiquete, MD, PhD
 
Acute stroke 2019
Acute stroke 2019Acute stroke 2019
MT Workshop Patient selection.pptx
MT Workshop Patient selection.pptxMT Workshop Patient selection.pptx
MT Workshop Patient selection.pptx
Gillian Gordon Perue
 
Experience of Vascular Interventional Procedures of Adana Numune Research and...
Experience of Vascular Interventional Procedures of Adana Numune Research and...Experience of Vascular Interventional Procedures of Adana Numune Research and...
Experience of Vascular Interventional Procedures of Adana Numune Research and...
ijtsrd
 
Stroke a rare complication in Post PCI patient
Stroke a rare complication in  Post PCI patientStroke a rare complication in  Post PCI patient
Stroke a rare complication in Post PCI patient
PRAVEEN GUPTA
 
An analysis of outcomes of emergency physician
An analysis of outcomes of emergency physicianAn analysis of outcomes of emergency physician
An analysis of outcomes of emergency physician
DrArpan Chouhan
 
Early management of acute ischemic stroke cases
Early management of acute ischemic stroke casesEarly management of acute ischemic stroke cases
Early management of acute ischemic stroke cases
Apollo Hospitals
 
Cilostazol for the prevention of acute progressing stroke. 2013
Cilostazol for the prevention of acute progressing stroke. 2013Cilostazol for the prevention of acute progressing stroke. 2013
Cilostazol for the prevention of acute progressing stroke. 2013
Javier Pacheco Paternina
 
Updated Nurses Pivotal Role in Stroke.ppt
Updated Nurses Pivotal Role in Stroke.pptUpdated Nurses Pivotal Role in Stroke.ppt
Updated Nurses Pivotal Role in Stroke.ppt
Hospital Antonio Lorena
 
Doctor James Doran
Doctor James DoranDoctor James Doran
Doctor James Doran
NACCHOpresentations
 
Preoperative Evaluaton of a surgical case
Preoperative Evaluaton of a surgical casePreoperative Evaluaton of a surgical case
Preoperative Evaluaton of a surgical case
ameenmb96
 
Stroke guidelines 2018.pptx
Stroke guidelines 2018.pptxStroke guidelines 2018.pptx
Stroke guidelines 2018.pptx
nitishkumar974360
 
Effect eng
Effect engEffect eng
Effect eng
NPSAIC
 
Thrombolysis and thrombectomy for acute ischaemic stroke
Thrombolysis and thrombectomy for acute ischaemic strokeThrombolysis and thrombectomy for acute ischaemic stroke
Thrombolysis and thrombectomy for acute ischaemic stroke
Han Naung Tun
 
Unanswered questions in thrombolytic therapy for acute ischemic stroke. 2013
Unanswered questions in thrombolytic therapy for acute ischemic stroke. 2013Unanswered questions in thrombolytic therapy for acute ischemic stroke. 2013
Unanswered questions in thrombolytic therapy for acute ischemic stroke. 2013
Javier Pacheco Paternina
 

Similar to Onset to Needle delay in Stroke Chain of Survival (20)

Identifying and managing acute stroke
Identifying and managing acute strokeIdentifying and managing acute stroke
Identifying and managing acute stroke
 
STEMI F5.pptx
STEMI F5.pptxSTEMI F5.pptx
STEMI F5.pptx
 
2017 ESC guidelines for the management of acute
2017 ESC guidelines for the management of acute2017 ESC guidelines for the management of acute
2017 ESC guidelines for the management of acute
 
Stroke- what's new
Stroke- what's newStroke- what's new
Stroke- what's new
 
a212b74434a2a0e4d2bee882e015987d.pdf
a212b74434a2a0e4d2bee882e015987d.pdfa212b74434a2a0e4d2bee882e015987d.pdf
a212b74434a2a0e4d2bee882e015987d.pdf
 
21. premier. english
21. premier. english21. premier. english
21. premier. english
 
Acute stroke 2019
Acute stroke 2019Acute stroke 2019
Acute stroke 2019
 
MT Workshop Patient selection.pptx
MT Workshop Patient selection.pptxMT Workshop Patient selection.pptx
MT Workshop Patient selection.pptx
 
Experience of Vascular Interventional Procedures of Adana Numune Research and...
Experience of Vascular Interventional Procedures of Adana Numune Research and...Experience of Vascular Interventional Procedures of Adana Numune Research and...
Experience of Vascular Interventional Procedures of Adana Numune Research and...
 
Stroke a rare complication in Post PCI patient
Stroke a rare complication in  Post PCI patientStroke a rare complication in  Post PCI patient
Stroke a rare complication in Post PCI patient
 
An analysis of outcomes of emergency physician
An analysis of outcomes of emergency physicianAn analysis of outcomes of emergency physician
An analysis of outcomes of emergency physician
 
Early management of acute ischemic stroke cases
Early management of acute ischemic stroke casesEarly management of acute ischemic stroke cases
Early management of acute ischemic stroke cases
 
Cilostazol for the prevention of acute progressing stroke. 2013
Cilostazol for the prevention of acute progressing stroke. 2013Cilostazol for the prevention of acute progressing stroke. 2013
Cilostazol for the prevention of acute progressing stroke. 2013
 
Updated Nurses Pivotal Role in Stroke.ppt
Updated Nurses Pivotal Role in Stroke.pptUpdated Nurses Pivotal Role in Stroke.ppt
Updated Nurses Pivotal Role in Stroke.ppt
 
Doctor James Doran
Doctor James DoranDoctor James Doran
Doctor James Doran
 
Preoperative Evaluaton of a surgical case
Preoperative Evaluaton of a surgical casePreoperative Evaluaton of a surgical case
Preoperative Evaluaton of a surgical case
 
Stroke guidelines 2018.pptx
Stroke guidelines 2018.pptxStroke guidelines 2018.pptx
Stroke guidelines 2018.pptx
 
Effect eng
Effect engEffect eng
Effect eng
 
Thrombolysis and thrombectomy for acute ischaemic stroke
Thrombolysis and thrombectomy for acute ischaemic strokeThrombolysis and thrombectomy for acute ischaemic stroke
Thrombolysis and thrombectomy for acute ischaemic stroke
 
Unanswered questions in thrombolytic therapy for acute ischemic stroke. 2013
Unanswered questions in thrombolytic therapy for acute ischemic stroke. 2013Unanswered questions in thrombolytic therapy for acute ischemic stroke. 2013
Unanswered questions in thrombolytic therapy for acute ischemic stroke. 2013
 

More from Wafik Bahnasy

Idiopathic intracranial hypertension, Looking for the black cat in the dark r...
Idiopathic intracranial hypertension, Looking for the black cat in the dark r...Idiopathic intracranial hypertension, Looking for the black cat in the dark r...
Idiopathic intracranial hypertension, Looking for the black cat in the dark r...
Wafik Bahnasy
 
True vs. pseudo papilledema, Dr. Jekyll and Mr. Hyde
True vs. pseudo  papilledema, Dr. Jekyll and Mr. HydeTrue vs. pseudo  papilledema, Dr. Jekyll and Mr. Hyde
True vs. pseudo papilledema, Dr. Jekyll and Mr. Hyde
Wafik Bahnasy
 
Uncommon primary headaches
Uncommon primary headachesUncommon primary headaches
Uncommon primary headaches
Wafik Bahnasy
 
White matter hyperintensities, the invisible invader
White matter hyperintensities, the invisible invaderWhite matter hyperintensities, the invisible invader
White matter hyperintensities, the invisible invader
Wafik Bahnasy
 
Controversies in Tremor disorder, Beyound the resting and kinetic oscillations
Controversies in Tremor disorder, Beyound the resting and kinetic oscillationsControversies in Tremor disorder, Beyound the resting and kinetic oscillations
Controversies in Tremor disorder, Beyound the resting and kinetic oscillations
Wafik Bahnasy
 
Tips, Pearls and Pitfalls of Spinal Cord MRI
Tips, Pearls and Pitfalls of Spinal Cord MRITips, Pearls and Pitfalls of Spinal Cord MRI
Tips, Pearls and Pitfalls of Spinal Cord MRI
Wafik Bahnasy
 
Women and Epilepsy
Women and EpilepsyWomen and Epilepsy
Women and Epilepsy
Wafik Bahnasy
 
Refractory Status epilepticus: A Time Travel
Refractory Status epilepticus: A Time TravelRefractory Status epilepticus: A Time Travel
Refractory Status epilepticus: A Time Travel
Wafik Bahnasy
 
Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum DisorderNeuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Wafik Bahnasy
 
Hematoma expansion after spontaneous intracerebral hemorrhage
Hematoma expansion after spontaneous intracerebral hemorrhageHematoma expansion after spontaneous intracerebral hemorrhage
Hematoma expansion after spontaneous intracerebral hemorrhage
Wafik Bahnasy
 
Primary monosymptomatic nocturnal enuresis
Primary monosymptomatic nocturnal enuresisPrimary monosymptomatic nocturnal enuresis
Primary monosymptomatic nocturnal enuresis
Wafik Bahnasy
 
Sleep abnormalities in Gullian Barre Syndrome Patients
Sleep abnormalities in Gullian Barre Syndrome PatientsSleep abnormalities in Gullian Barre Syndrome Patients
Sleep abnormalities in Gullian Barre Syndrome Patients
Wafik Bahnasy
 
Gullian Barre Syndrome
Gullian Barre SyndromeGullian Barre Syndrome
Gullian Barre Syndrome
Wafik Bahnasy
 
Polysomnogram interpretetion
Polysomnogram interpretetionPolysomnogram interpretetion
Polysomnogram interpretetion
Wafik Bahnasy
 
Transcranial Magnetic Stimulation
Transcranial Magnetic StimulationTranscranial Magnetic Stimulation
Transcranial Magnetic Stimulation
Wafik Bahnasy
 
Parkinson Disease MDS criteria
Parkinson Disease MDS criteriaParkinson Disease MDS criteria
Parkinson Disease MDS criteria
Wafik Bahnasy
 
Alzheimer's disease new drugs, 2017
Alzheimer's disease new drugs, 2017Alzheimer's disease new drugs, 2017
Alzheimer's disease new drugs, 2017
Wafik Bahnasy
 
REM behaviour disorder and dementia with Lewy bodies
REM behaviour disorder and dementia with Lewy bodiesREM behaviour disorder and dementia with Lewy bodies
REM behaviour disorder and dementia with Lewy bodies
Wafik Bahnasy
 
Alzheimer's disease and sex hormones
Alzheimer's disease and sex hormonesAlzheimer's disease and sex hormones
Alzheimer's disease and sex hormones
Wafik Bahnasy
 
Alzheimer's disease and sex hormones
Alzheimer's disease and sex hormonesAlzheimer's disease and sex hormones
Alzheimer's disease and sex hormones
Wafik Bahnasy
 

More from Wafik Bahnasy (20)

Idiopathic intracranial hypertension, Looking for the black cat in the dark r...
Idiopathic intracranial hypertension, Looking for the black cat in the dark r...Idiopathic intracranial hypertension, Looking for the black cat in the dark r...
Idiopathic intracranial hypertension, Looking for the black cat in the dark r...
 
True vs. pseudo papilledema, Dr. Jekyll and Mr. Hyde
True vs. pseudo  papilledema, Dr. Jekyll and Mr. HydeTrue vs. pseudo  papilledema, Dr. Jekyll and Mr. Hyde
True vs. pseudo papilledema, Dr. Jekyll and Mr. Hyde
 
Uncommon primary headaches
Uncommon primary headachesUncommon primary headaches
Uncommon primary headaches
 
White matter hyperintensities, the invisible invader
White matter hyperintensities, the invisible invaderWhite matter hyperintensities, the invisible invader
White matter hyperintensities, the invisible invader
 
Controversies in Tremor disorder, Beyound the resting and kinetic oscillations
Controversies in Tremor disorder, Beyound the resting and kinetic oscillationsControversies in Tremor disorder, Beyound the resting and kinetic oscillations
Controversies in Tremor disorder, Beyound the resting and kinetic oscillations
 
Tips, Pearls and Pitfalls of Spinal Cord MRI
Tips, Pearls and Pitfalls of Spinal Cord MRITips, Pearls and Pitfalls of Spinal Cord MRI
Tips, Pearls and Pitfalls of Spinal Cord MRI
 
Women and Epilepsy
Women and EpilepsyWomen and Epilepsy
Women and Epilepsy
 
Refractory Status epilepticus: A Time Travel
Refractory Status epilepticus: A Time TravelRefractory Status epilepticus: A Time Travel
Refractory Status epilepticus: A Time Travel
 
Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum DisorderNeuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
 
Hematoma expansion after spontaneous intracerebral hemorrhage
Hematoma expansion after spontaneous intracerebral hemorrhageHematoma expansion after spontaneous intracerebral hemorrhage
Hematoma expansion after spontaneous intracerebral hemorrhage
 
Primary monosymptomatic nocturnal enuresis
Primary monosymptomatic nocturnal enuresisPrimary monosymptomatic nocturnal enuresis
Primary monosymptomatic nocturnal enuresis
 
Sleep abnormalities in Gullian Barre Syndrome Patients
Sleep abnormalities in Gullian Barre Syndrome PatientsSleep abnormalities in Gullian Barre Syndrome Patients
Sleep abnormalities in Gullian Barre Syndrome Patients
 
Gullian Barre Syndrome
Gullian Barre SyndromeGullian Barre Syndrome
Gullian Barre Syndrome
 
Polysomnogram interpretetion
Polysomnogram interpretetionPolysomnogram interpretetion
Polysomnogram interpretetion
 
Transcranial Magnetic Stimulation
Transcranial Magnetic StimulationTranscranial Magnetic Stimulation
Transcranial Magnetic Stimulation
 
Parkinson Disease MDS criteria
Parkinson Disease MDS criteriaParkinson Disease MDS criteria
Parkinson Disease MDS criteria
 
Alzheimer's disease new drugs, 2017
Alzheimer's disease new drugs, 2017Alzheimer's disease new drugs, 2017
Alzheimer's disease new drugs, 2017
 
REM behaviour disorder and dementia with Lewy bodies
REM behaviour disorder and dementia with Lewy bodiesREM behaviour disorder and dementia with Lewy bodies
REM behaviour disorder and dementia with Lewy bodies
 
Alzheimer's disease and sex hormones
Alzheimer's disease and sex hormonesAlzheimer's disease and sex hormones
Alzheimer's disease and sex hormones
 
Alzheimer's disease and sex hormones
Alzheimer's disease and sex hormonesAlzheimer's disease and sex hormones
Alzheimer's disease and sex hormones
 

Recently uploaded

Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 

Recently uploaded (20)

Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 

Onset to Needle delay in Stroke Chain of Survival

  • 1.
  • 2.
  • 3. ◘ AIS is defined as an episode of neurological dysfunction caused by focal cerebral, spinal or retinal infarction. ◘ In developed countries stroke had dropped from the 2nd to the 5th cause of death (after heart diseases, cancer, chronic lower respiratory diseases and accidents). ◘ On the other hand, in developing countries stroke still impacted as the 2nd cause of death.
  • 4. ◘ 20% of stroke survivors are unable to return to work, 10% will have another stroke within one year, 30% require assistance with activities of daily living, 18% require assistance with ambulation, and 16% require institutional care. ◘ Better stroke prognosis is attributed to greater awareness of stroke symptoms and improved care within the first hours of onset.
  • 5. ◘ In 1996, the FDA approved IV r-tPA as the only therapy for early AIS management and since this date many efforts had spent to reduce the stoke onset/needle time due to the narrow therapeutic window. ◘ Many stroke patients are elderly who reside alone or with their spouse with limited support from younger generations. These patients are unable to do anything beyond alarming the system.
  • 6.
  • 7. ◘ Till intra-arterial reperfusion, 2 million neurons are lost each minute and every 30-min delay reduces the relative likelihood of a good clinical outcome by 15%. ◘ < 1.4 % of AIS patients receive IV r-tPA in the first 60 minutes. ◘ The rate of IV thrombolysis in the window is 3.4 – 9.1 % of AIS patients.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. ◘ The call to the EMS stroke center is the first link in the SCS which must be activated at once. ◘ The dispatcher must not leave the scene before establishing the Time ZERO which is defined as the time at which the patient was last known or seen normal. .
  • 13. 1- Describe the various types of stroke and their etiology. 2- Discuss the imperatives for best practice in regard to EMS stroke management. 3- List 5 or more risk factors for acute stroke. 4- Define “penumbra” and how this concept is important in stroke. 5- Generally describe the major vessels involved in acute ischemic stroke. 6- Discuss the “therapeutic window” for thrombolytic therapy in stroke. 7- Identify interventions that individual EMS providers can make to improve outcomes in stroke.
  • 14. 1- ABC and IV access. 2- O2 administration if Sa O2 < 95% (routine use is not recommended). 3- No need for pre-hospital management of high blood pressure or elevated body temperature. 4- For hypotension, horizontal placement of the stretcher head and isotonic saline. 5- No need for insulin administration in hyperglycemia. 6- IV glucose if RBS is below 60 mg/dl. 7- No benefits from the pre-hospital use of neuroprotective e.g. nimodipine or magnesium sulphate.
  • 15. (1) Rapid stroke identification. (2) Early stabilization of vital functions. (3) Rapid transport to closest available certified stroke ready hospital. - Bypass the stroke non-ready hospitals. - Air medical transport is considered when ground transport is >1 hour. (4) Pre-arrival hospital notification.
  • 16. Theprobabilityofstrokeis 72%in patientwith1 probabilityand85%inwhomhas3 probabilities
  • 17.
  • 18.
  • 19. ◘ EMS personnel should provide prehospital notification to improve the readiness of the hospital team which shorten the door to needle time by about 15 minutes. ◘ Teleradiology systems had approved for sites without in-house imaging interpretation expertise.
  • 20. ◘ Tele-stroke/teleradiology evaluations of AIS patients can be effective for correct IV r-tPA eligibility decision making. ◘ Administration of IV r-tPA guided by tele-stroke consultation for patients with AIS which is as safe as the stroke centers.
  • 21.
  • 22.
  • 23. ◘ ABCs should be reassessed and rechecked frequently. ◘ Stroke assessment focusing on the 4 key issues: 1- Level of consciousness. 2- Type of stroke (hemorrhagic versus non- hemorrhagic). 3- Location of stroke (carotid versus vertebra-basilar). 4- Severity of stroke.
  • 24. ◘ Obtaining the exact time of stroke onset (time zero). ◘ NIHSS. ◘ CT initiation & interpretation. ◘ Anticoagulants and fibrinolytic agents should be withheld until CT has ruled out a brain hemorrhage. ◘ Stroke Mimics (Chameleons): - Unrecognized seizures. - Confusional states. - Syncope. - Toxic or metabolic disorders. - Hypoglycemia. - Brain tumors. - Subdural hematoma. - Psychogenic.
  • 25. ◘ For ( * ) marked investigations, IV r-tPA should not be delayed while awaiting their results. ◘ Non-contrast brain CT or brain MRI ◘ Blood glucose ◘ Oxygen saturation ◘ Serum electrolytes/renal function tests * ◘ Complete blood count, including platelet count * ◘ Markers of cardiac ischemia * ◘ PT/INR * ◘ Activated PTT * ◘ ECG * All patients Selected patients ◘ Ecarin clotting time & thrombin time (if pt. receiving direct thrombin or direct factor Xa inhibitors). ◘ Hepatic function tests ◘ Toxicology screen ◘ Blood alcohol level ◘ Pregnancy test ◘ Arterial blood gas tests ◘ Chest radiography ◘ Lumbar puncture (if SAH is suspected and CT scan is negative) ◘ EEG (if seizures are suspected)
  • 26. ◘ General care includes, (but is not limited to): 1- Prevention of aspiration. 2- Management of hypertension. 3- Management of hyper/hypo-glycemia. 4- Management of seizures. 5- Management of elevated intra-cranial pressure (ICP).
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34. ◘ The front-line stroke-ready hospitals quickly administer r-tPA then transport patients to a more advanced center withbetter stroke treatment facilities.
  • 35. ◘ Written emergency stroke care protocols. ◘ Written transfer agreement to a hospital with neurosurgical expertise in less than 2 hours. ◘ Director of stroke care to oversee hospital stroke policies and procedure. ◘ 24 / 7 ability to administer IV r-tPA. ◘ 24 / 7 ability to perform emergency brain CT. ◘ 24 / 7 ability to perform emergency laboratory testing. ◘ No need of invasive catheter procedure or specialized stroke ICU.
  • 36. ◘ Availability of advanced imaging techniques, including MRI/MRA, CTA, DSA and TCD. ◘ Ready for all CVS management i.e. ischemic, hemorrhagic and SAH. ◘ 24 / 7 ready IV r-tPA and endovascular team able for mechanical thrombectomy. ◘ Availability of specialized stroke ICU. ◘ 24 /7 neurosurgical team able to perform aneurysm clipping, vascular malformation surgery and carotid endarterectomy.
  • 37.
  • 38.
  • 39. ◘ Bringing swift treatment to the patient, instead of the conventional approach of awaiting the patient’s arrival at the hospital. ◘ This strategy is based on the use of an ambulance (mobile stroke unit) equipped with an imaging system, a point-of-care laboratory, a telemedicine connection to the hospital, and appropriate medication.
  • 40.
  • 41.
  • 42. ◘ While building a SCS system, do not look for the unreachable solutions, but always adjust the system regarding the available resources. ◘ SCS is a dynamic process that needs continuous evaluation, quality assessment and updating to identify and solve gaps as well as disparities in providing stroke care. ◘ Do not think about mobile stroke units while you are wasting > extra 40 minutes in the door / needle time.
  • 43. ◘ The EAN is not convinced in the value of generalization the German STEMO trial which decreases the alarm / needle time by about 25 minutes (52 minutes STEMO vs. 77 minutes ordinary SCS). ◘ In Australia, air medical transport reduced alarm / needle time by 30 minutes. ◘ The clinical data regarding the value pre-hospital laboratory investigations in reducing the door / needle time are contradictory.
  • 44. 1- Increasing social awareness. 2- Training the EMS staff. 3- Arrangement with the Directorate of Health Affairs in Gharbia Governorate to set up the drip and ship strategy. 4- Financial support (governmental, third party agencies and the civil society institutions), for reimbursement of the r-tPA. 5- The administrative procedures, laboratory investigations and imaging steps should be done in the same building and simultaneously rather than consecutively.
  • 45. [1] Caplan, JAMA Neurology; 2017. doi: 10.1001/jamaneurol.2017.0006 [2] Espinoza et al. Cerebrovascular Diseases; 2016. doi: 10.1159/000444175 [3] Bahnasy et al., eNeurologicalSci 2019; doi: 10.1016/j.ensci.2019.01.003 [4] Abu-Hegazy et al. EJNPN; 2017. doi: 10.4103/1110-1083.202377 [5] Feigin et al. Circ Res; 2017. doi: 10.1161/CIRCRESAHA.116.308413 [6] Badachi et al. Annals of Indian Academy of Neurology; 2015. doi: 10.4103/0972-2327.165460 [7] Valenzuela et al. Cerebrovascular Diseases; 2016. doi: 10.1159/000444175 [8] Fonarow et al. Circulation; 2011. doi: 10.1161/CIRCULATIONAHA.110.974675 [9] Kassebaum et al. Lancet; 2016. doi: 10.1016/S0140-6736(16)31460-X [10] Brandler et al. J. Stroke and Cerebrovascular D; 2015. doi: 10.1016/j.jstrokecerebrovasdis.2015.06.004 [11] Cheng et al. Neurohospitalist; 2015. doi: 10.1177/1941874415583116 [12] Dombrowski et al. Stroke; 2015. doi: 10.1161/STROKEAHA.115.009997 [13] Nishijima et al. Journal of the Neurological Sciences; 2017. doi: 10.1016/j.jns.2017.08.3236 [14] Farrag et al. J Neurol Sci; 2018. doi: 10.1016/j.jns.2017.11.003 [15] Ruiz et al. J. Stroke and Cerebrovascular D; 2018. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.036 [17] Hansen et al. J Neurosci Rural Pract; 2017. doi: 10.4103/jnrp.jnrp_2_17 [18] Ghandehari et al. Stroke Res Treat; 2011. doi: 10.4061/2011/686797 [19] Paul et al. Implementation Science; 2016. doi: 10.1186/s13012-016-0414-6 [20] Fernandes et al. BMJ Quality Improvement Reports. 2016. doi: 10.1136/bmjquality.u212969.w5150 [21] Powers et al. Stroke; 2018. doi: 10.1161/STR.0000000000000158 [22] Meschia et al. European Journal of Neurology; 2018. doi:10.1111/ene.13409 [23] Puolakka et al. J Am Heart Assoc; 2016. doi: 10.1161/JAHA.115.002808
  • 46. Center of Neurology and Psychiatry, Tanta University